Archives
Clinical trial participation plunges worldwide, in Asia due to COVID-19 pandemic
The COVID-19 pandemic is hampering the initiation and progress of clinical trials in Asia and around the world. Few patients are entering studies, and trials of new treatments are on hold. In Korea, the number of new patients enrolling in clinical... Read More
RAPS Wisconsin Chapter Webcast: Embracing The Growth – An Update on MedTech in Asia
https://attendee.gotowebinar.com/recording/5890292005019691021 Read More
U.S. grants tariff relief for medical equipment, face masks, other medical goods from China
With U.S. medical personnel and institutions facing key supply shortages in fighting the COVID-19 virus outbreak, trade officials in March removed tariffs on dozens of medical items imported from China. The tariff exemptions on face masks, exam gloves, surgical drapes, protective gowns,... Read More
Artificial Intelligence Boom in Asia increasingly affecting collection of data, disease research
As the use of artificial intelligence (AI) takes hold in Asia’s healthcare industry, researchers are collecting detailed health profiles of citizens and using the data to test treatments, monitor adverse drug reactions in patients, detect the risk of cognitive issues in children... Read More
Nine categories of medical devices exempt from new U.S. tariffs on China
The Trump administration will exempt certain categories of medical devices and medical equipment from hefty tariffs it slapped on $34 billion of Chinese imports to the U.S., offering relief to some U.S, firms. The narrow list of exemptions will provide relief from... Read More
Chinese funds to US biotechs to be limited under Trump
The US government is now determining whether Chinese investment into certain industries jeopardizes US intellectual property. In addition to about 25 other industries, biotech companies may now be reviewed by the committee for foreign investment into the US even with respect to... Read More
China Retaliates with Tariffs on U.S. Health Products
On August 3, in response to the Trump administration’s threats to add $200 billion of tariffs on Chinese goods, the Chinese Ministry of Commerce announced that they will tax 5% to 25% on an additional $60 billion worth of U.S. goods. The... Read More
Surge of Chinese Investment to U.S. Biotech May be Threatened
Flush with cash and eager to gain earlier and easier access to innovative drug technologies, Chinese investors have been pumping money into Western biotech startups over the past two years. But despite this recent trend, U.S. President Donald Trump’s plan to limit... Read More
Trump’s Tariffs Negatively Affect the U.S. Medical Industry
The Trump administration’s first set of tariffs, which will affect about $800 million worth of imported medical devices and components, will be imposed on July 6, 2018. According to Minnesota’s Star Tribune, for many Minnesota medtech companies, China is the largest global... Read More